WAM
VRXA

Wolverine Asset Management’s Veraxa Biotech AG VRXA Stock Holding History

Wolverine Asset Management’s Portfolio VRXA Stock Details VRXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.29K Buy
+1,748
New +$14K ﹤0.01% 1515

Other funds holding VRXA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Wolverine Asset Management's VRXA Position: Q2 2026 in Review

Wolverine Asset Management opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 1,748 shares worth $3.29K. The stake represents ﹤0.01% of the portfolio and ranks #1515 among its holdings.

6 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

  • Wolverine Asset Management held 1,748 shares of Veraxa Biotech AG worth $3.29K as of Q2 2026.
  • Veraxa Biotech AG was a new Wolverine Asset Management position in Q2 2026.
  • Veraxa Biotech AG made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1515 holding.
  • 6 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.